---
title: "GT Biopharma reports Q1 results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286567387.md"
description: "GT Biopharma reports Q1 results"
datetime: "2026-05-15T12:42:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286567387.md)
  - [en](https://longbridge.com/en/news/286567387.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286567387.md)
---

# GT Biopharma reports Q1 results


### Related Stocks

- [GTBP.US](https://longbridge.com/en/quote/GTBP.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [EXCLUSIVE: GT Biopharma Begins Testing Of Lead Solid Tumor Drug Candidate Across Multiple Cancer Types](https://longbridge.com/en/news/286415809.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [Candel Therapeutics Reports Positive Phase 3 Prostate Cancer Trial Data](https://longbridge.com/en/news/286652611.md)